Abstract:ID 131189 Poster Board 456 Medulloblastoma is the most common malignant pediatric brain tumor, accounting for nearly 20% of all CNS neoplasms in children. The disease comprises four distinct subtypes: SHH, WNT, Group 3, and Group 4. The Group 3 and Group 4 subtypes account for around 60% of all cases and are characterized by unfavorable prognosis, poor treatment outcome, and a higher prevalence in males than females. The genetic underpinning of medulloblastoma has not been fully understood and the intricacies of its genetic architecture warrant in-depth exploration to enhance our understanding of tumorigenesis and enable better therapeutic strategies. In this investigative study, our primary objective was to discover prominent Single Nucleotide Polymorphisms (SNPs) enriched in medulloblastoma patients on chromosome X for which hypermutation has been implicated in tumorigenesis. Employing genomic analysis techniques, we meticulously aligned sequences to genes situated on chromosome X, drawing from a comprehensive cohort of medulloblastoma patients from the public database Sequence Read Archive (SRA) to the reference human genome sourced from Ensembl. Cross-referenced mutations were identified and analyzed using Python genome analysis programs and statistical assessments to discern variant associations between our medulloblastoma and control groups were undertaken using chi-square tests. Our analysis brought to the forefront genes FTX, CROCCP1, TTC3P1, KANTR, and AP2B1P, all of which exhibited pronounced SNP concentrations in medulloblastoma patients. The FTX gene exhibited significant results, with over 200 unique SNPs identified. Following closely, the CROCCP1, TTC3P1, KANTR, and AP2B1P genes were each found to have between 120 and 140 unique SNPs. Intriguingly, while these genes have received peripheral attention in prior medulloblastoma-centric research, our findings bring to light their potential importance in the disease's genetic landscape. FTX and KANTR are both genes that regulate the production of LncRNAs which, despite not encoding for proteins, may play a significant role in gene expression and have been found to regulate tumor suppression and promotion. CROCCP1, TTC3P1, and AP2B1P, on the other hand, are pseudogenes, which may influence regulatory networks. Though once believed to have little impact on protein function, pseudogenes have recently been found to influence gene expression regulation and microRNA activity, which can therefore play roles in tumor suppression. Our findings underscore the influence of specific genes and their associated SNPs, emphasizing their prospective roles in disease onset, progression, and potential therapeutic interventions for medulloblastoma patients.

Whole Genome Sequencing Identifies Key Genes in Spinal Schwannoma

Whole genome and RNA sequencing of 1,220 cancers reveals hundreds of genes deregulated by rearrangement of cis-regulatory elements

Gene mutation at chromosome 22 in sporadic patients with spinal schwannomatosis: A preliminary analysis

Epigenetic reprogramming shapes the cellular landscape of schwannoma

Identification of Key Pathways and Genes in Vestibular Schwannoma Using Bioinformatics Analysis.

Identification of Key Biomarkers and Immune Infiltration in Sporadic Vestibular Schwannoma Basing Transcriptome-Wide Profiling

The Analysis of NF2 Gene Mutation in Sporadic Schwannomas

Genomic characterization of intracranial teratomas using whole genome sequencing

Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients

Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.

Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis

Whole-genome sequencing of an advanced case of small-cell gallbladder neuroendocrine carcinoma

Clinical and molecular features of sacrum chordoma in Chinese patients

High SNP concentrations on the X-chromosome suggest prospective gene targets FTX, CROCCP1, TTC3P1, KANTR, and AP2B1P in medulloblastoma

Identifying Key Somatic Copy Number Alterations Driving Dysregulation of Cancer Hallmarks in Lower-Grade Glioma

Age-dependent Copy Number Variations of TP53 Tumour Suppressor Gene Associated with Altered Phosphorylation Status of P53 Protein in Sporadic Schwannomas

Genomic Landscapes by Multiregion Sequencing Combined with Circulation Tumor DNA Detection Contribute to Molecular Diagnosis in Glioblastomas

Whole-genome Sequencing Reveals the Mutational Landscape of Metastatic Small-Cell Gallbladder Neuroendocrine Carcinoma (GB-SCNEC).

Comprehensive analysis of diagnosis and treatment in 99 cases of abdominal Schwannoma

Biom-47. Single Nucleotide Polymorphism In Smarcb1 Mutation For Schwannomatosis

A Comprehensive Understanding of the Genomic Bone Tumor Landscape: A Multicenter Prospective Study